Sedation Strategies for Diagnostic Bronchoscopy

• Status: Terminated
• Trial end date: 2018-03-31
• Target enrollment: 0
• Participant gender: All

Summary

Diagnostic bronchoscopy is an invasive procedure performed to diagnose respiratory diseases. But pain has been complained by most of the patients receiving such procedures. Sedation or anesthesia was required by both of the patients and bronchoscopists. Unfortunately, no consensus has been made upon the sedation strategies. Multiple sedation approaches have been applied, such as midazolam and fentanyl, remifentanil and propofol, dexmedetomidine and propofol. The present study was designed to compare these protocols in sedation for diagnostic bronchoscopy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Changhai Hospital
• Collaborators: Ruijin Hospital; Shanghai Pulmonary Hospital, Shanghai, China; Shanghai Zhongshan Hospital
• Treatments: Dexmedetomidine; Fentanyl; Midazolam; Propofol; Remifentanil

Criteria

Inclusion Criteria:

• Scheduled for flexible diagnostic bronchoscopy

• Adult patients aged 18 to 65 years

• American Society of Anesthesiologists (ASA) Physical Status Classification I-II

• BMI 18.5-25kg/m2

• Subjects provide informed consent

Exclusion Criteria:

• Severe airway obstruction

• Coagulation disorder

• Repeat bronchoscopy (more than 3 times)

• Severe liver and renal dysfunction

• Cardiovascular and cerebrovascular diseases

• Pregnancy

• Chronic opioid user

• Drug abusers or addicts